نتائج البحث - "Harm van Tinteren"

1

Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer

المؤلفون: Erik van Dijk, Erik van Werkhoven, Rebecca Asher, Jennifer K. Mooi, David Espinoza, Hendrik F. van Essen, Harm van Tinteren, Nicole C. T. van Grieken, Cornelis J. A. Punt, Niall C. Tebbutt, Bauke Ylstra

المساهمون: Pathology, CCA - Imaging and biomarkers, Amsterdam Gastroenterology Endocrinology Metabolism, AII - Cancer immunology, Hematology, Graduate School, APH - Methodology, APH - Personalized Medicine, Oncology

المصدر: van Dijk, E, van Werkhoven, E, Asher, R, Mooi, J K, Espinoza, D, van Essen, H F, van Tinteren, H, van Grieken, N C T, Punt, C J A, Tebbutt, N C & Ylstra, B 2022, ' Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer : A post hoc analysis of the randomized phase III-trial AGITG-MAX ', International Journal of Cancer, vol. 151, no. 7, pp. 1166-1174 . https://doi.org/10.1002/ijc.34061Test
International Journal of Cancer, 151(7), 1166-1174. Wiley-Liss Inc.

مصطلحات موضوعية: Cancer Research, Rectal Neoplasms, metastatic colorectal cancer, chromosome 18q, bevacizumab, anti-VEGF monoclonal antibody, Chromosomes, Disease-Free Survival, Oncology, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms, randomized controlled trial, Humans, Fluorouracil, Chromosome Deletion, Colorectal Neoplasms, predictive biomarker, Retrospective Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9484dc470126a2b8047680b89c1c03aTest
https://doi.org/10.1002/ijc.34061Test

2

Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols

المصدر: European Journal of Cancer. 163:88-97

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d423cc7c73ca5b0829430698cd44c340Test
https://doi.org/10.1016/j.ejca.2021.12.014Test

3

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer

المؤلفون: Theo J. Klinkenberg, Vincent van der Noort, Harry J.M. Groen, Corinne Kloosterziel, Hans J.M. Smit, Egbert F. Smit, Frans M. N. H. Schramel, Otto S. Hoekstra, Erik H.F.M. van der Heijden, Harm van Tinteren, Ben E. E. M. van den Borne, Ad F.T.M. Verhagen, RM Pieterman, Anne-Marie C. Dingemans, Joachim G.J.V. Aerts, Bonne Biesma

المساهمون: Radiology and nuclear medicine, CCA - Cancer Treatment and quality of life, ACS - Heart failure & arrhythmias, Pulmonary Medicine, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: British Journal of Cancer, 121(5), 372-377. Nature Publishing Group
British Journal of Cancer, 121, 372-377
Groen, H J M, van der Heijden, E H F M, Klinkenberg, T J, Biesma, B, Aerts, J, Verhagen, A, Kloosterziel, C, Pieterman, R, van den Borne, B, Smit, H J M, Hoekstra, O, Schramel, F M N H, van der Noort, V, van Tinteren, H, Smit, E F, Dingemans, A-M C & NVALT Study Group, the Netherlands 2019, ' Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study ', British Journal of Cancer, vol. 121, no. 5, pp. 372-377 . https://doi.org/10.1038/s41416-019-0533-3Test
British Journal of Cancer
British Journal of Cancer, 121, 5, pp. 372-377

مصطلحات موضوعية: Male, Cancer Research, Lung Neoplasms, MULTICENTER, Phases of clinical research, Deoxycytidine, Gastroenterology, THERAPY, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Pneumonectomy, Nadroparin, MOLECULAR-WEIGHT HEPARIN, Middle Aged, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, SURVIVAL, Female, Segmental resection, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.medical_specialty, medicine.drug_class, Low molecular weight heparin, Pemetrexed, Disease-Free Survival, Article, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, POSITRON-EMISSION-TOMOGRAPHY, SDG 3 - Good Health and Well-being, Fluorodeoxyglucose F18, Internal medicine, medicine, Humans, Lung cancer, Aged, Neoplasm Staging, business.industry, Other Research Radboud Institute for Health Sciences [Radboudumc 0], Anticoagulants, Retrospective cohort study, medicine.disease, Gemcitabine, Clinical trial, PET, Positron-Emission Tomography, Cisplatin, Neoplasm Recurrence, Local, business, Non-small-cell lung cancer, SCAN

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d6d03d0f2c38227c153e75187b2fe21Test
https://doi.org/10.1038/s41416-019-0533-3Test

4

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

المساهمون: Internal medicine, Medical oncology, CCA - Cancer Treatment and quality of life, Oncology, CCA - Cancer Treatment and Quality of Life, Medical Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Interne Geneeskunde

المصدر: Jama Oncology, 6, 4, pp. 528-534
JAMA Oncology, 6(4), 528-534. American Medical Association
Steenbruggen, T G, Steggink, L C, Seynaeve, C M, Van Der Hoeven, J J M, Hooning, M J, Jager, A, Konings, I R, Kroep, J R, Smit, W M, Tjan-Heijnen, V C G, Van Der Wall, E, Bins, A D, Linn, S C, Schaapveld, M, Jacobse, J N, Van Leeuwen, F E, Schröder, C P, Van Tinteren, H, De Vries, E G E, Sonke, G S & Gietema, J A 2020, ' High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients with High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes : 20-Year Follow-up of a Phase 3 Randomized Clinical Trial ', JAMA Oncology, vol. 6, no. 4, pp. 528-534 . https://doi.org/10.1001/jamaoncol.2019.6276Test
JAMA oncology, 6(4), 528-534. American Medical Association
JAMA Oncology, 6(4), 528-534. AMER MEDICAL ASSOC
JAMA Oncol
Jama Oncology, 6, 528-534

مصطلحات موضوعية: Cancer Research, efficacy, 0302 clinical medicine, Cumulative incidence, Breast, 030212 general & internal medicine, Child, Original Investigation, support, benefit, Hazard ratio, Hematopoietic Stem Cell Transplantation, WOMEN, Middle Aged, Chemotherapy regimen, medicine.anatomical_structure, Oncology, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Female, Fluorouracil, medicine.drug, Epirubicin, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Adult, medicine.medical_specialty, recurrence, Axillary lymph nodes, Cardiovascular Abnormalities, Breast Neoplasms, ThioTEPA, Disease-Free Survival, 03 medical and health sciences, Breast cancer, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, conventional adjuvant chemotherapy, medicine, Humans, Cyclophosphamide, therapy, Dose-Response Relationship, Drug, business.industry, Cancer, medicine.disease, Axilla, Lymph Nodes, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc75b5fa1a0ce92730e37111e77ccec6Test
https://hdl.handle.net/2066/218567Test

5

Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group

المؤلفون: Aurore Coulomb-L'Hermine, Beatriz de Camargo, Claudia Pasqualini, J. Godzinski, Kathy Pritchard-Jones, Gordan M. Vujanic, Harm van Tinteren, Hervé Brisse, Arnauld Verschuur, Christophe Bergeron, Roberto Augusto Plaza Teixeira, Rhoikos Furtwängler, Patrick Melchior, Norbert Graf, Anne M. J. B. Smets, Lisa Howell, Marry M. van den Heuvel-Eibrink, T Acha

المساهمون: Graduate School, Radiology and Nuclear Medicine, AGEM - Digestive immunity, AGEM - Re-generation and cancer of the digestive system, APH - Mental Health, CCA - Cancer Treatment and Quality of Life, ARD - Amsterdam Reproduction and Development

المصدر: European journal of cancer (Oxford, England, 128, 38-46. Elsevier Limited

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, Multivariate analysis, Time Factors, Adolescent, Wilms tumour, Postoperative radiotherapy, Renal tumour, Gastroenterology, Wilms Tumor, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Blastema, TP53, Prospective Studies, Prospective cohort study, Child, Anaplasia, Wilms, Cancer, Neoplasm Staging, business.industry, Infant, medicine.disease, Kidney Neoplasms, Survival Rate, 030104 developmental biology, Oncology, Vincristine, 030220 oncology & carcinogenesis, Child, Preschool, Dactinomycin, Disease Progression, Female, medicine.symptom, Neoplasm Recurrence, Local, Stage iv, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554bdf04e6acb8dcb6617651e0a60d6fTest
https://pubmed.ncbi.nlm.nih.gov/32109849Test

6

Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001

المؤلفون: Norbert Graf, Christophe Bergeron, Foppe Oldenburger, Kathy Pritchard-Jones, Jan Godzinski, Harm van Tinteren, Gema L. Ramírez-Villar, Martine van Grotel, Beatriz de Camargo, Gordan M. Vujanic, Marry M. van den Heuvel-Eibrink, Janna A. Hol, Marta Lopez-Yurda

المساهمون: Academic Medical Center

المصدر: PLoS ONE, Vol 14, Iss 8, p e0221373 (2019)
PLoS ONE
PLoS ONE, 14(8):e0221373. Public Library of Science

مصطلحات موضوعية: Male, medicine.medical_treatment, 030232 urology & nephrology, Cancer Treatment, Kidney, Pediatrics, Nephrectomy, 0302 clinical medicine, Informed consent, Interquartile range, Surgical oncology, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Medicine, Blastomas, Prospective Studies, Stage (cooking), Prospective cohort study, Child, Nephroblastoma, Multidisciplinary, medicine.diagnostic_test, Pharmaceutics, Age Factors, Prognosis, Kidney Neoplasms, Tumor Burden, Surgical Oncology, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Child, Preschool, Female, Anatomy, Risk assessment, Research Article, Clinical Oncology, medicine.medical_specialty, Histology, Adolescent, Wilms tumour, Science, Surgical and Invasive Medical Procedures, Risk Assessment, Wilms Tumor, Disease-Free Survival, 03 medical and health sciences, Cancer Chemotherapy, Drug Therapy, Diagnostic Medicine, Internal medicine, Biopsy, Pediatric oncology, Chemotherapy, Humans, Kidney surgery, Neoplasm Staging, business.industry, Patient Selection, Cancer, Biology and Life Sciences, Cancers and Neoplasms, Infant, medicine.disease, Pediatric Oncology, Clinical Medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93473445755841cd0337e5d3fe8c40d4Test
https://doi.org/10.1371/journal.pone.0221373Test

7

Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only : Results from the SIOP-WT-2001 Registry

المؤلفون: Harm van Tinteren, Geert O. Janssens, Eva Oldenburger, Kathy Pritchard-Jones, Norbert Graf, Christophe Bergeron, Foppe Oldenburger, Martine van Grotel, Christian Rübe, Marta Lopez-Yurda, Raquel Davila Fajardo, Marry M. van den Heuvel-Eibrink, Daniel Saunders

المساهمون: Radiotherapy, CCA - Cancer Treatment and Quality of Life

المصدر: Pediatric Blood and Cancer, 65(8). Wiley-Liss Inc.
Pediatric blood & cancer, 65(8):e27085. Wiley-Liss Inc.

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_treatment, Salvage therapy, intermediate risk, Kaplan-Meier Estimate, Pediatrics, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Registries, Stage (cooking), Child, Chemoradiotherapy, Hematology, lymph node, Wilms tumour, Perinatology, Kidney Neoplasms, and Child Health, Oncology, Vincristine, Child, Preschool, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Dactinomycin, Boost irradiation, Female, Lymph, Radiology, boost, medicine.medical_specialty, Wilms Tumor, Disease-Free Survival, 03 medical and health sciences, medicine, Humans, In patient, Pediatrics, Perinatology, and Child Health, radiotherapy, Retrospective Studies, business.industry, Infant, Radiation therapy, 030104 developmental biology, Clinical Trials, Phase III as Topic, Pediatrics, Perinatology and Child Health, Radiotherapy, Adjuvant, Intermediate risk, business

وصف الملف: image/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::627c33cafb4c917f2b3d8fe6ee7be333Test
https://dspace.library.uu.nl/handle/1874/368964Test

8

Gain of 1q as a prognostic biomarker in Wilms Tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial: a SIOP renal tumours biology consortium study

المساهمون: Other departments, CCA -Cancer Center Amsterdam, Paediatric Oncology

المصدر: Journal of clinical oncology, 34(26), 3195-3203. American Society of Clinical Oncology
Journal of Clinical Oncology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c08514350ec0c59cb7e3b983c76f0ab9Test
https://orca.cardiff.ac.uk/id/eprint/103143/1/jco.2015.66.0001.pdfTest

9

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial

المؤلفون: Philip C. Schouten, Sabine C. Linn, Jan H.M. Schellens, Serena Marchetti, Gwen M. H. E. Dackus, Gabe S. Sonke, Harm van Tinteren

المساهمون: Sub Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

المصدر: Trials, 17. BioMed Central
Trials
Trials [E], 17. BioMed Central

مصطلحات موضوعية: Compassionate Use Trials, 0301 basic medicine, Oncology, Time Factors, endocrine system diseases, Receptor, ErbB-2, Medicine (miscellaneous), Piperazines, law.invention, Carboplatin, Study Protocol, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Olaparib, Clinical Protocols, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Medicine, Drug Dosage Calculations, Pharmacology (medical), skin and connective tissue diseases, PARP inhibitors, Netherlands, BRCA1 Protein, Metastatic breast cancer, Phenotype, Treatment Outcome, Research Design, 030220 oncology & carcinogenesis, Disease Progression, Metastatic, Female, medicine.drug, medicine.medical_specialty, Breast Neoplasms, Disease-Free Survival, Capecitabine, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, Journal Article, Humans, Genetic Predisposition to Disease, neoplasms, BRCA2 Protein, Gynecology, Cisplatin, business.industry, Cancer, medicine.disease, BRCA1, BRCA2, 030104 developmental biology, chemistry, Mutation, Phthalazines, business, Homologous recombination deficiency

وصف الملف: image/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c841964b62fe92487f7f4434c1ecbd3bTest
https://dspace.library.uu.nl/handle/1874/346937Test

10

The contribution of chest CT-scan at diagnosis in children with unilateral Wilms’ tumour. Results of the SIOP 2001 study

المؤلفون: Christophe Bergeron, Kathy Pritchard-Jones, Beatriz de Camargo, Norbert Graf, Harm van Tinteren, Anne M. J. B. Smets, Jan de Kraker

المساهمون: Radiology and Nuclear Medicine, Paediatric Oncology

المصدر: European journal of cancer (Oxford, England, 48(7), 1060-1065. Elsevier Limited

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48413260531bf732c32a754535d9ddfTest
https://doi.org/10.1016/j.ejca.2011.05.025Test

تنقيح النتائج